{"name": "arGEN-X",
 "permalink": "argen-x",
 "crunchbase_url": "http://www.crunchbase.com/company/argen-x",
 "homepage_url": "http://www.argen-x.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@argen-x.com",
 "phone_number": "+31 (0)10 70 38 441",
 "description": "antibody technology",
 "created_at": "Mon Sep 14 14:15:00 UTC 2009",
 "updated_at": "Thu Dec 06 02:24:38 UTC 2012",
 "overview": "\u003Cp\u003ETo this end, arGEN-X has invented and developed a breakthrough discovery platform setting the new standard for antibody lead choice in the discovery of human antibody therapeutics.\u003C/p\u003E\n\n\u003Cp\u003EFuelled by the best possible natural immune responses available, our Simple Antibody\u00e2\u201e\u00a2 platform leapfrogs existing platforms in what is probably the most critical aspect of drug discovery and development: lead choice.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[137,
       56],
      "assets/images/resized/0005/9706/59706v1-max-150x150.png"],
     [[137,
       56],
      "assets/images/resized/0005/9706/59706v1-max-250x250.png"],
     [[137,
       56],
      "assets/images/resized/0005/9706/59706v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$45.6M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.fiercebiotech.com/story/argen-x-gins-13-6m-new-funds-mab-work/2009-09-10?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
    "source_description": "arGEN-X gins $13.6M in new funds for mAB work",
    "raised_amount": 13600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 9,
    "funded_day": 10,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Forbion Capital Partners",
         "permalink": "forbion-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0010/0907/100907v1-max-150x150.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-250x250.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "KBC",
         "permalink": "kbc",
         "image":
          {"available_sizes":
            [[[109,
               104],
              "assets/images/resized/0005/9128/59128v1-max-150x150.jpg"],
             [[109,
               104],
              "assets/images/resized/0005/9128/59128v1-max-250x250.jpg"],
             [[109,
               104],
              "assets/images/resized/0005/9128/59128v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BioGeneration Ventures",
         "permalink": "biogeneration-ventures",
         "image":
          {"available_sizes":
            [[[150,
               8],
              "assets/images/resized/0004/6055/46055v2-max-150x150.jpg"],
             [[250,
               14],
              "assets/images/resized/0004/6055/46055v2-max-250x250.jpg"],
             [[343,
               20],
              "assets/images/resized/0004/6055/46055v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Erasmus MC Biomedical Fund",
         "permalink": "erasmus-mc-biomedical-fund",
         "image":
          {"available_sizes":
            [[[150,
               61],
              "assets/images/resized/0004/5488/45488v1-max-150x150.jpg"],
             [[241,
               99],
              "assets/images/resized/0004/5488/45488v1-max-250x250.jpg"],
             [[241,
               99],
              "assets/images/resized/0004/5488/45488v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://onbiovc.com/argen-x-bv-series-a-45m/",
    "source_description": "arGEN-X, BV: Series A $4.5M",
    "raised_amount": 4500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 2,
    "funded_day": 11,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Credit Agricole Private Equity",
         "permalink": "credit-agricole-private-equity",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0002/3491/23491v3-max-150x150.jpg"],
             [[250,
               68],
              "assets/images/resized/0002/3491/23491v3-max-250x250.jpg"],
             [[450,
               123],
              "assets/images/resized/0002/3491/23491v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Forbion Capital Partners",
         "permalink": "forbion-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0010/0907/100907v1-max-150x150.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-250x250.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Life Sciences Partners",
         "permalink": "life-sciences-partners",
         "image":
          {"available_sizes":
            [[[146,
               66],
              "assets/images/resized/0004/7976/47976v1-max-150x150.jpg"],
             [[146,
               66],
              "assets/images/resized/0004/7976/47976v1-max-250x250.jpg"],
             [[146,
               66],
              "assets/images/resized/0004/7976/47976v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "KBC",
         "permalink": "kbc",
         "image":
          {"available_sizes":
            [[[109,
               104],
              "assets/images/resized/0005/9128/59128v1-max-150x150.jpg"],
             [[109,
               104],
              "assets/images/resized/0005/9128/59128v1-max-250x250.jpg"],
             [[109,
               104],
              "assets/images/resized/0005/9128/59128v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BioGeneration Ventures",
         "permalink": "biogeneration-ventures",
         "image":
          {"available_sizes":
            [[[150,
               8],
              "assets/images/resized/0004/6055/46055v2-max-150x150.jpg"],
             [[250,
               14],
              "assets/images/resized/0004/6055/46055v2-max-250x250.jpg"],
             [[343,
               20],
              "assets/images/resized/0004/6055/46055v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Erasmus MC Biomedical Fund",
         "permalink": "erasmus-mc-biomedical-fund",
         "image":
          {"available_sizes":
            [[[150,
               61],
              "assets/images/resized/0004/5488/45488v1-max-150x150.jpg"],
             [[241,
               99],
              "assets/images/resized/0004/5488/45488v1-max-250x250.jpg"],
             [[241,
               99],
              "assets/images/resized/0004/5488/45488v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Thuja Capital",
         "permalink": "thuja-capital",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0008/1888/81888v1-max-150x150.jpg"],
             [[225,
               45],
              "assets/images/resized/0008/1888/81888v1-max-250x250.jpg"],
             [[225,
               45],
              "assets/images/resized/0008/1888/81888v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.finsmes.com/2011/12/argen-x-closes-e27-5m-series-funding.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "arGEN-X Closes \u00e2\u201a\u00ac27.5M Series B Funding Round",
    "raised_amount": 27500000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2011,
    "funded_month": 12,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Forbion Capital Partners",
         "permalink": "forbion-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0010/0907/100907v1-max-150x150.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-250x250.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Credit Agricole Private Equity",
         "permalink": "credit-agricole-private-equity",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0002/3491/23491v3-max-150x150.jpg"],
             [[250,
               68],
              "assets/images/resized/0002/3491/23491v3-max-250x250.jpg"],
             [[450,
               123],
              "assets/images/resized/0002/3491/23491v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "LSP BioVentures",
         "permalink": "lsp-bioventures",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Erasmus MC Biomedical Fund",
         "permalink": "erasmus-mc-biomedical-fund",
         "image":
          {"available_sizes":
            [[[150,
               61],
              "assets/images/resized/0004/5488/45488v1-max-150x150.jpg"],
             [[241,
               99],
              "assets/images/resized/0004/5488/45488v1-max-250x250.jpg"],
             [[241,
               99],
              "assets/images/resized/0004/5488/45488v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Seventure Partners",
         "permalink": "seventure-partners",
         "image":
          {"available_sizes":
            [[[150,
               55],
              "assets/images/resized/0022/4088/224088v2-max-150x150.png"],
             [[226,
               83],
              "assets/images/resized/0022/4088/224088v2-max-250x250.png"],
             [[226,
               83],
              "assets/images/resized/0022/4088/224088v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "Dr Molewaterplein 50",
    "address2": "",
    "zip_code": "3015",
    "city": "Rotterdam",
    "state_code": null,
    "country_code": "NLD",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}